Terms: = Endocrine gland cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
80 results:
1. Expression landscape of cancer-foxp3 and its prognostic value in pancreatic adenocarcinoma.
Gong R; Wang J; Xing Y; Wang J; Chen X; Lei K; Yu Q; Zhao C; Li S; Zhang Y; Wang H; Ren H
Cancer Lett; 2024 May; 590():216838. PubMed ID: 38561039
[TBL] [Abstract] [Full Text] [Related]
2. An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma.
Wang X; Ren T; Liao C; Xie Y; Cao J
BMC Genomics; 2024 Feb; 25(1):205. PubMed ID: 38395786
[TBL] [Abstract] [Full Text] [Related]
3. Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma.
Li S; Chen Z; Liu M; Li L; Cai W; Lian ZX; Guan H; Xu B
Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38214937
[TBL] [Abstract] [Full Text] [Related]
4. CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy.
Schoumacher C; Derangère V; Gaudillière-Le Dain G; Huppe T; Rageot D; Ilie A; Vienot A; Borg C; Monnien F; Bibeau F; Truntzer C; Ghiringhelli F;
Oncoimmunology; 2024; 13(1):2294563. PubMed ID: 38169969
[TBL] [Abstract] [Full Text] [Related]
5. Identification of foxp3
Gong R; Chen X; Sun X; Zhang Y; Wang J; Yu Q; Lei K; Ren H
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C294-C303. PubMed ID: 38047300
[TBL] [Abstract] [Full Text] [Related]
6. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma.
Ashina S; Masuda A; Yamakawa K; Hamada T; Tsujimae M; Tanaka T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Harada Y; Miki M; Juri N; Irie Y; Kanzawa M; Itoh T; Inoue J; Imai T; Fukumoto T; Kodama Y
J Gastroenterol; 2023 Oct; 58(10):1055-1067. PubMed ID: 37477731
[TBL] [Abstract] [Full Text] [Related]
8. Role of Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Could It Be Considered a Predictor of prognosis?
De Simoni O; Dal Santo L; Scarpa M; Munari G; Spolverato YC; Scapinello A; Lonardi S; Soldà C; Bergamo F; Fantin A; Bardini R; Pilati P; Fassan M; Gruppo M
Curr Oncol; 2023 Jun; 30(6):5515-5528. PubMed ID: 37366900
[TBL] [Abstract] [Full Text] [Related]
9. Association of Sarcopenia with a Poor prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis.
Masuda S; Yamakawa K; Masuda A; Toyama H; Sofue K; Nanno Y; Komatsu S; Omiya S; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Ashina S; Gonda M; Abe S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
Ann Surg Oncol; 2023 Sep; 30(9):5776-5787. PubMed ID: 37191859
[TBL] [Abstract] [Full Text] [Related]
10. Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer.
Bartl T; Alberts A; Papadopoulos SC; Wolf A; Muellauer L; Hofstetter G; Grimm C; Cacsire Castillo-Tong D
Int J Gynecol Cancer; 2023 Sep; 33(9):1419-1426. PubMed ID: 37094966
[TBL] [Abstract] [Full Text] [Related]
11. VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
Jlassi A; Manai M; Morjen M; Sahraoui G; Elasmi Allal M; ELBini-Dhouib I; Naija L; Charfi L; Rejaibi R; Ben Ahmed M; Marrakchi N; Srairi-Abid N; Mezlini A; Manai M; Mrad K; Doghri R
PLoS One; 2023; 18(3):e0278849. PubMed ID: 36952478
[TBL] [Abstract] [Full Text] [Related]
12. Spontaneous Murine Model of Anaplastic Thyroid cancer.
Yan H; Ma Y; Zhou X; He Y; Liu Y; Caulin C; Wang L; Xu H; Luo H
J Vis Exp; 2023 Feb; (192):. PubMed ID: 36804915
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers.
Kim JE; Kim H; Kim B; Chung HG; Chung HH; Kim KM; Kim SH; Jeong WK; Kim YK; Min JH; Heo JS; Han IW; Shin SH; Park HC; Yu JI; Park JO; Kim ST; Hong JY; Lee SH; Lee KH; Lee JK; Lee KT; Jang KT; Park JK
Cancer Med; 2023 Apr; 12(7):7748-7761. PubMed ID: 36650632
[TBL] [Abstract] [Full Text] [Related]
14. Effect of FOXP2 transcription factor on immune infiltration of thyroid cancer and its potential clinical value.
Xu L; Yang Z; Zhao Q; Feng H; Kuang J; Liu Z; Chen L; Zhan L; Yan J; Cai W; Qiu W
Front Immunol; 2022; 13():982812. PubMed ID: 36203616
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.
Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J
Front Immunol; 2022; 13():942154. PubMed ID: 35936015
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.
Marchenko S; Piwonski I; Hoffmann I; Sinn BV; Kunze CA; Monjé N; Pohl J; Kulbe H; Schmitt WD; Darb-Esfahani S; Braicu EI; von Brünneck AC; Sehouli J; Denkert C; Horst D; Jöhrens K; Taube ET
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2523-2536. PubMed ID: 35763108
[TBL] [Abstract] [Full Text] [Related]
17. Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.
Gartrell RD; Enzler T; Kim PS; Fullerton BT; Fazlollahi L; Chen AX; Minns HE; Perni S; Weisberg SP; Rizk EM; Wang S; Oh EJ; Guo XV; Chiuzan C; Manji GA; Bates SE; Chabot J; Schrope B; Kluger M; Emond J; Rabadán R; Farber D; Remotti HE; Horowitz DP; Saenger YM
Oncoimmunology; 2022; 11(1):2066767. PubMed ID: 35558160
[TBL] [Abstract] [Full Text] [Related]
18. The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas.
Matsuura H; Miyamoto M; Hada T; Ishibashi H; Iwahashi H; Kakimoto S; Suzuki R; Ito T; Suminokura J; Tsuda H; Takano M
Arch Gynecol Obstet; 2022 Dec; 306(6):2133-2142. PubMed ID: 35507079
[TBL] [Abstract] [Full Text] [Related]
19. Overexpression of
Jiang S; Yang Y; Zhang Y; Ye Q; Song J; Zheng M; Li X
Dis Markers; 2022; 2022():9719671. PubMed ID: 35186171
[TBL] [Abstract] [Full Text] [Related]
20. Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer.
Sasaki T; Nishiwada S; Nakagawa K; Nagai M; Terai T; Hokuto D; Yasuda S; Matsuo Y; Doi S; Sho M
Int J Clin Oncol; 2022 May; 27(5):948-957. PubMed ID: 35142963
[TBL] [Abstract] [Full Text] [Related]
[Next]
